Walgreens Participation In 340B Program Probed By Sen. Grassley
This article was originally published in The Pink Sheet Daily
Grassley suggests concern that the big pharmacy chain’s participation in the program may lead to diversion, in which drugs purchased at discounted 340B pricing are dispensed to insured individuals, allowing the pharmacy to profit from the difference in payments.
You may also be interested in...
In the first study to analyze data for 340B-discounted drugs dispensed at contract retail pharmacies, researchers found antivirals were dispensed at more than 10 times the rate seen for all scripts at Walgreens, the largest 340B contract pharmacy. The largest source of 340B contract pharmacy prescriptions was tuberculosis clinics.
A group supported by drug manufacturers and pharmacy benefit managers – the Alliance for Integrity and Reform of 340B – is pushing Congress to alter how hospitals qualify for discounted drugs under the 340B program.
Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.